0001140361-23-039344.txt : 20230811 0001140361-23-039344.hdr.sgml : 20230811 20230811212220 ACCESSION NUMBER: 0001140361-23-039344 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230809 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lundbeckfond Invest A/S CENTRAL INDEX KEY: 0001591046 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 231165900 BUSINESS ADDRESS: STREET 1: SCHERFIGSVEJ 7 CITY: COPENHAGEN STATE: G7 ZIP: DK-2100 BUSINESS PHONE: 4540307375 MAIL ADDRESS: STREET 1: SCHERFIGSVEJ 7 CITY: COPENHAGEN STATE: G7 ZIP: DK-2100 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 form4.xml X0508 4 2023-08-09 0001865494 IO Biotech, Inc. IOBT 0001591046 Lundbeckfond Invest A/S C/O IO BIOTECH, INC. OLE MAALOES VEJ 3 COPENHAGEN G7 2200 DENMARK true true false Common Stock 2023-08-09 4 A 0 7901234 1.9 A 13950686 D Warrants (Right to Buy) 2.47 2023-08-09 4 A 0 7901234 0.125 A 2023-08-09 Common Stock 7901234 7901234 D These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023). Christian Elling is Managing Partner of Lundbeckfonden Emerge, a division of Lundbeckfond Invest A/S, and currently serves as the representative of Lundbeckfond Invest A/S on the Issuer's board of directors, and therefore Lundbeckfond Invest A/S may be deemed a "director by deputization" of the Issuer. Lundbeckfond Invest A/S, by: /s/ Brian Burkavage, Attorney-in-Fact for Christian Elling, Managing Partner, and Lene Skole, Chief Executive Officer 2023-08-11